A Phase 2 Study to Assess the Safety and Efficacy of Intravitreal ONL1204 Ophthalmic Solution in Subjects With Mac-off Retinal Detachment

Part of paid clinical trials in Phoenix, Arizona.

Sponsor
ONL Therapeutics
Study ID
NCT05730218
Phase
PHASE2
Status
Completed

Conditions

  • Rhegmatogenous Retinal Detachment - Macula Off

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • ONL1204 Ophthalmic Solution — DRUG
    ONL1204 Ophthalmic Solution at one of two doses delivered via intravitreal injection
  • Sham treatment — DRUG
    Sham injection is performed by touching the eye surface with a syringe without a needle

Study Details

The goal of this Phase 2 clinical trial is to learn about ONL1204 Ophthalmic Solution in terms of safety and how well the drug works in patients that have a macula-off (central point of vision) rhegmatogenous retinal detachment (RRD). The main questions it aims to answer are: * Does ONL1204 improve vision in macula-off RRD patients when used before retinal detachment repair surgery compared to patients that have surgery alone? * Is ONL1204 safe to use as an add-on drug before retinal repair surgery? Researchers will observe patients that receive two different dosages of ONL1204 Ophthalmic Solution (50 µg or 200 µg) compared to current standard therapy (no treatment) to see if there are differences in vision and safety outcomes.

Key Dates

First listed
Feb 15, 2023
Start date
Apr 4, 2023
Status verified
Feb 2024
Primary completion
Feb 21, 2024
Completion
Feb 21, 2024

Study Design

Enrollment
136 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Treatment Group A
    ONL1204 Ophthalmic Solution Dose A administered by intravitreal injection
  • Experimental: Treatment Group B
    ONL1204 Ophthalmic Solution Dose B administered by intravitreal injection
  • Sham Comparator: Treatment Group C
    Sham injection is performed by touching the eye surface with a syringe without a needle

Primary Outcome Measure

Mean area under the log contrast sensitivity function (AULCSF) [ Time Frame: Week 24 ]

Locations (36)

FacilityCityStateZIPSite coordinators
Associated Retina ConsultantsPhoenixArizona85020-
Retina Associates SW PCTucsonArizona85704-
Win RetinaArcadiaCalifornia91006-
Global Research Management, Inc.GlendaleCalifornia91204-
Salehi Retina Institute, Inc.Huntington BeachCalifornia92647-
Florida Retina InstituteJacksonvilleFlorida32216-
Florida Retina ConsultantsLakelandFlorida33805-
Retina Specialty InstitutePensacolaFlorida32503-
Sarasota Retina InstituteSarasotaFlorida34239-
Retina Vitreous Associates of FloridaSt. PetersburgFlorida33711-
Retina Specialists of TampaWesley ChapelFlorida33544-
Marietta Eye ClinicMariettaGeorgia30060-
Retina Associates, LtdElmhurstIllinois60126-
Retina Associates, Ltd.ElmhurstIllinois60126-
Midwest Eye InstituteCarmelIndiana46290-
Cumberland Valley Retina ConsultantsHagerstownMaryland21740-
University of Michigan Kellogg Eye CenterAnn ArborMichigan48105-
Mayo ClinicRochesterMinnesota55905-
The Retina InstituteSt LouisMissouri63144-
Retina Vitreous Surgeons of CNY, PCLiverpoolNew York13088-
Retina Associates of Western NY, PCRochesterNew York14620-
Velocity Clinical Research, Inc.CincinnatiOhio45202-
Oregon Health & Science University - Casey Eye InstitutePortlandOregon97239-
Erie Retina Research, LLCEriePennsylvania16507-
Charleston Neuroscience InstituteLadsonSouth Carolina29456-
Palmetto Retina Center, LLCWest ColumbiaSouth Carolina29169-
Opthalmology LtdSioux FallsSouth Dakota57108-
Southeastern Retina AssociatesChattanoogaTennessee37421-
Charles Retina InstituteGermantownTennessee38138-
Retina Research Institute of TexasAbileneTexas79606-
Austin Research Center for RetinaAustinTexas78705-
Retina Consultants of TexasBeaumontTexas77707-
Valley Retina Institute, P.A.McAllenTexas78503-
San Antonio Eye CenterSan AntonioTexas78215-
Retina Consultants of TexasThe WoodlandsTexas77384-
Retina Center NW, PLLCSilverdaleWashington98383-

Find similar trials in Phoenix, AZ